1-碘-3-甲基双环[1.1.1]戊烷 | 136399-10-5

• 分子结构分类: 有机化合物 - 有机卤素化合物 - 有机碘化物
• 中文名称: 1-碘-3-甲基双环[1.1.1]戊烷
• 英文名称: 1-iodo-3-methylbicyclo[1.1.1]pentane
• 英文别名: 1-iodo-3-methylbicyclo<1.1.1>pentane
• CAS: 136399-10-5
• 化学式: C₆H₉I
• 分子量: 208.042
• InChiKey: KKJUVXJKGMIUEC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  7
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

安全信息

• 危险类别：
  8,3
• 危险性防范说明：
  P210,P233,P240,P241,P242,P243,P260,P264,P280,P301+P330+P331,P303+P361+P353,P304+P340,P305+P351+P338,P310,P363,P370+P378,P403+P235,P405,P501
• 危险品运输编号：
  2920
• 危险性描述：
  H225,H314
• 包装等级：
  II
• 储存条件：
  室温

反应信息

• 作为反应物：
  描述：

  1-碘-3-甲基双环[1.1.1]戊烷 在 盐酸 、 叠氮磷酸二苯酯 、 叔丁基锂 、 三乙胺 作用下， 以 1,4-二氧六环 、 乙醚 、 乙酸乙酯 、 正戊烷 为溶剂， 反应 45.67h， 生成 3-methylbicyclo[1.1.1]pentan-1-amine hydrochloride
  参考文献：
  名称：

  [EN] SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH
  [FR] DIAMINOCARBOXAMIDEPYRIMIDINES ET DIAMINOCARBONITRILEPYRIMIDINES SUBSTITUÉES, COMPOSITIONS DE CELLES-CI ET PROCÉDÉS DE TRAITEMENT À L'AIDE DE CELLES-CI

  摘要：

  本文提供具有以下结构的二氨基嘧啶化合物：其中R1、R2、R3和R4如本文所定义，包含有效量二氨基嘧啶化合物的组合物，以及用于治疗或预防肝纤维化疾病或通过抑制JNK途径可治疗或预防的疾病的方法。

  公开号：

  WO2012145569A1
• 作为产物：
  描述：

  1,3-二碘双环[1.1.1]戊烷 在 氢氧化钾 作用下， 以 乙醚 、 苯 为溶剂， 反应 2.5h， 生成 1-碘-3-甲基双环[1.1.1]戊烷
  参考文献：
  名称：

  Formation and Reactions of Bicyclo[1.1.1]pentyl-1 Cations

  摘要：

  The ionization of l-bicyclo[1.1.1]pentyl halides was shown to initially form the 1,3-bridged bicycle[1.1.1]pentyl-l cation. It appears to be a transition state that leads to the bicyclo[1.1.0]butyl-1-carbinyl cation which can be trapped with azide ion and can be directly observed by NMR in SO2CIF. Although the major products of solvolysis of the halides are 3-methylenecyclobutyl derivatives, the corresponding cation was calculated to have a significantly higher energy than the bicyclobutylcarbinyl ion. Therefore, the products are probably formed by an attack of the nucleophile on the latter ion, accompanied by bond migration. The bridgehead iodide reacts under solvolytic conditions with azide ion to form bicyclo[1.1.0]butyl-l azide as a product. It also reacts with potassium hydroxide to give [1.1.1]propellane, and the same reaction occurs on dissolving in acetonitrile or pyridine. The reaction of 1,3-diiodobicyclo[1.1.1]pentane with ethoxide ion also was found to give [1.1.1]propellane via a nucleophilic attack on one of the iodines. The propellane reacts with methyl hypoiodite to give 3-iodobicyclo[1.1.1]pentyl-l cation, which can react with methanol to give 3-methoxybicyclo[1.1.1]pentyl-l iodide and with azide ion to give 3-iodobicyclo[1.1.1]pentyl-1 azide. These data provide evidence for a discrete 3-iodobicyclo[1.1.1]pentyl-l cation intermediate. The effect of substituents on the rate of solvolysis of bicyclo[1.1.1]pentyl-l iodide was studied. With 3-aryl substituents, a value of rho = -1.7 was found, which is similar to that observed in the solvolysis of 3-arylcyclobutyl tosylates (rho = -1.6). The 3-substituted bicyclopentyl halides usually form the corresponding 3-methylenecyclobutyl cations rather than bicyclo[1.1.0]butyl-1-carbinyl ions, because most substituents will help stabilize the former type of ion.

  DOI：

  10.1021/ja00105a046

文献信息

• [EN] BICYCLIC COMPOUNDS<br/>[FR] COMPOSÉS BICYCLIQUES
  申请人：KALYRA PHARMACEUTICALS INC

  公开号：WO2016044331A1

  公开（公告）日：2016-03-24

  Disclosed herein are compounds of Formulae (I) and (II), methods of synthesizing compounds of Formulae (I) and (II), and methods of using compounds of Formulae (I) and (II) as an analgesic.

  本文披露了化合物的化学式(I)和(II)，合成化合物的方法的化学式(I)和(II)，以及将化合物的化学式(I)和(II)用作镇痛剂的方法。
• [EN] BCL-2 PROTEIN INHIBITORS<br/>[FR] INHIBITEURS DE PROTÉINE BCL-2
  申请人：RECURIUM IP HOLDINGS LLC

  公开号：WO2021007307A1

  公开（公告）日：2021-01-14

  Various Bcl-2 protein inhibitors are described, along with methods of using them to treat conditions characterized by excessive cellular proliferation, such as cancer and tumors. In various embodiments the Bcl-2 protein inhibitors are compounds or pharmaceutically acceptable salts of the following Formula (I), where the variables in Formula (I) are defined herein.

  描述了各种Bcl-2蛋白抑制剂，以及使用它们治疗过度细胞增殖的疾病的方法，如癌症和肿瘤。在各种实施例中，Bcl-2蛋白抑制剂是以下式（I）的化合物或药用可接受盐，其中式（I）中的变量在此处定义。
• [EN] BENZAMIDE COMPOUNDS<br/>[FR] COMPOSÉS BENZAMIDE
  申请人：ZENO ROYALTIES & MILESTONES LLC

  公开号：WO2019139902A1

  公开（公告）日：2019-07-18

  Compounds of Formula (I) are provided herein. Such compounds, as well as pharmaceutically acceptable salts and compositions thereof, are useful for treating diseases or conditions, including conditions characterized by excessive cellular proliferation, such as cancer and tumors, as well as viral infections such as HIV.

  本文提供了化学式(I)的化合物。这些化合物以及其药用盐和组合物可用于治疗疾病或病况，包括由细胞过度增殖引起的病况，如癌症和肿瘤，以及病毒感染如HIV。
• [EN] NANOPARTICLE FORMULATION OF BCL-2 INHIBITOR<br/>[FR] FORMULATION DE NANOPARTICULES D'INHIBITEUR DE LA BCL-2
  申请人：RECURIUM IP HOLDINGS LLC

  公开号：WO2021007303A1

  公开（公告）日：2021-01-14

  Various albumin nanoparticle Bcl-2 inhibitor formulations are described, along with methods of using them to treat conditions characterized by excessive cellular proliferation, such as cancer and tumors. In various embodiments, such Bcl-2 inhibitor formulations contain albumin and a compound of the following Formula (I), or a pharmaceutically acceptable salt thereof, where the variables in Formula (I) are defined herein.

  描述了各种白蛋白纳米颗粒Bcl-2抑制剂配方，以及使用它们治疗由细胞过度增殖所表征的疾病的方法，例如癌症和肿瘤。在各种实施例中，这种Bcl-2抑制剂配方包含白蛋白和以下化合物的化合物（I）或其药用可接受的盐，其中化合物（I）中的变量在此处定义。
• Nickel- and Palladium-Catalyzed Cross-Coupling Reactions at the Bridgehead of Bicyclo[1.1.1]pentane Derivatives - A Convenient Access to Liquid Crystalline Compounds Containing Bicyclo[1.1.1]pentane Moieties
  作者：Matthias Messner、Sergei I. Kozhushkov、Armin de Meijere

  DOI：10.1002/1099-0690(200004)2000:7<1137::aid-ejoc1137>3.0.co;2-2

  日期：2000.4

  Pd(PPh3)4, or PdCl2(dppf) catalysis to give a number of 1,3-disubstituted bicyclo[1.1.1]pentyl derivatives 17, 20, and 23, several of which exhibit liquid crystalline properties, in moderate to very good yields. The coupling products 20ca, 23ab, 23ae, 23ff, and 23fg have been further transformed to yield bicyclo[1.1.1]pentyl derivatives 32, 24ab, 24ae, 27ff, and 27fg, respectively, bearing alkynyl, cyano

  有机碘化物 7a-s 在 [1.1.1] 推进烷 (2) 上的自由基加成反应，然后是卤素-锂交换和与氯化锌的金属转移，以及将格利雅试剂添加到 2，提供了各种 3-取代双环[1.1.1]pentyl-1-magnesium (14) 和-zinc (19) 衍生物。后者在 NiCl2dppe、Pd(PPh3)4 或 PdCl2(dppf) 催化下与各种烯基、芳基和联芳基卤化物和三氟甲磺酸酯偶联，得到许多 1,3-二取代的双环 [1.1.1] 戊基衍生物 17 、20和23，其中一些表现出液晶性质，产率中等至非常好。偶联产物 20ca、23ab、23ae、23ff 和 23fg 已进一步转化为双环 [1.1.1] 戊基衍生物 32、24ab、24ae、27ff 和 27fg，分别带有炔基、氰基和/或烯基.